UV Germi SA
UV Germi SA designs, manufactures, and sells ultraviolet devices for the treatment of air, water, and surfaces in France. The company offers its products in the areas of drinking water, seawater, dechloramination, wastewater and industrial process water, private pool, legionella, germiserre, small flow rates, ageing, industrial clean water, and livestock farming industries. It also provides after… Read more
UV Germi SA (ALUVI) - Net Assets
Latest net assets as of June 2025: €10.20 Million EUR
Based on the latest financial reports, UV Germi SA (ALUVI) has net assets worth €10.20 Million EUR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€11.45 Million) and total liabilities (€1.26 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €10.20 Million |
| % of Total Assets | 89.01% |
| Annual Growth Rate | 19.71% |
| 5-Year Change | 48.82% |
| 10-Year Change | 401.6% |
| Growth Volatility | 84.11 |
UV Germi SA - Net Assets Trend (2014–2024)
This chart illustrates how UV Germi SA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for UV Germi SA (2014–2024)
The table below shows the annual net assets of UV Germi SA from 2014 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €9.88 Million | +8.45% |
| 2023-12-31 | €9.11 Million | +3.12% |
| 2022-12-31 | €8.83 Million | +49.72% |
| 2021-12-31 | €5.90 Million | -11.12% |
| 2020-12-31 | €6.64 Million | +6.59% |
| 2019-12-31 | €6.23 Million | +1.56% |
| 2018-12-31 | €6.13 Million | -5.65% |
| 2017-12-31 | €6.50 Million | +281.10% |
| 2016-12-31 | €1.71 Million | -13.40% |
| 2015-12-31 | €1.97 Million | +20.49% |
| 2014-12-31 | €1.63 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to UV Germi SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 117.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €293.30K | 3.03% |
| Common Stock | €484.18K | 5.01% |
| Other Comprehensive Income | €27.72K | 0.29% |
| Other Components | €8.87 Million | 91.68% |
| Total Equity | €9.67 Million | 100.00% |
UV Germi SA Competitors by Market Cap
The table below lists competitors of UV Germi SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Original Juice Co. Ltd.
AU:OJC
|
$3.30 Million |
|
ASIA-PACIFIC STR.INV.LTD.
F:2HN
|
$3.30 Million |
|
EXCELLENCE S.A. ZY -10
F:8XY
|
$3.30 Million |
|
Sadbhav Infrastructure Project Limited
NSE:SADBHIN
|
$3.31 Million |
|
ANORF
PINK:ANORF
|
$3.30 Million |
|
Buyuk Sefler Gida Turizm
IS:BIGCH
|
$3.30 Million |
|
Landi Renzo S.p.A.
F:ARQ0
|
$3.30 Million |
|
PRCRF
PINK:PRCRF
|
$3.30 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in UV Germi SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 9,110,978 to 9,672,617, a change of 561,639 (6.2%).
- Net income of 709,927 contributed positively to equity growth.
- Other comprehensive income increased equity by 1.
- Other factors decreased equity by 148,289.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €709.93K | +7.34% |
| Other Comprehensive Income | €1.00 | +0.0% |
| Other Changes | €-148.29K | -1.53% |
| Total Change | €- | 6.16% |
Book Value vs Market Value Analysis
This analysis compares UV Germi SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.76x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 3.27x to 0.76x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | €0.71 | €2.32 | x |
| 2015-12-31 | €0.85 | €2.32 | x |
| 2016-12-31 | €0.74 | €2.32 | x |
| 2017-12-31 | €2.52 | €2.32 | x |
| 2018-12-31 | €2.40 | €2.32 | x |
| 2019-12-31 | €2.43 | €2.32 | x |
| 2020-12-31 | €2.58 | €2.32 | x |
| 2021-12-31 | €2.25 | €2.32 | x |
| 2022-12-31 | €2.79 | €2.32 | x |
| 2023-12-31 | €2.87 | €2.32 | x |
| 2024-12-31 | €3.04 | €2.32 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently UV Germi SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.34%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.34%
- • Asset Turnover: 0.77x
- • Equity Multiplier: 1.14x
- Recent ROE (7.34%) is above the historical average (-1.42%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 8.26% | 4.04% | 1.38x | 1.48x | €-28.37K |
| 2015 | -4.99% | -2.31% | 1.20x | 1.81x | €-295.26K |
| 2016 | -14.06% | -5.43% | 1.40x | 1.85x | €-410.39K |
| 2017 | -2.87% | -3.92% | 0.58x | 1.25x | €-836.51K |
| 2018 | -5.89% | -6.76% | 0.66x | 1.32x | €-974.57K |
| 2019 | 1.54% | 1.49% | 0.77x | 1.34x | €-527.28K |
| 2020 | 6.18% | 6.16% | 0.70x | 1.43x | €-253.67K |
| 2021 | -15.07% | -13.76% | 0.81x | 1.35x | €-1.45 Million |
| 2022 | 0.76% | 0.92% | 0.66x | 1.25x | €-801.26K |
| 2023 | 3.18% | 3.61% | 0.77x | 1.14x | €-621.01K |
| 2024 | 7.34% | 8.34% | 0.77x | 1.14x | €-257.33K |
Industry Comparison
This section compares UV Germi SA's net assets metrics with peer companies in the Pollution & Treatment Controls industry.
Industry Context
- Industry: Pollution & Treatment Controls
- Average net assets among peers: $19,412,870
- Average return on equity (ROE) among peers: -17.76%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| UV Germi SA (ALUVI) | €10.20 Million | 8.26% | 0.12x | $3.30 Million |
| BIO UV Group (ALTUV) | $30.70 Million | 2.25% | 1.64x | $18.19 Million |
| Osmosun SA (ALWTR) | $8.13 Million | -37.77% | 0.50x | $818.09K |